Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
AssigneeMerck Sharp & Dohme Corp.
InventorsHelen Jane Bryant, Mark Stuart Chambers, Philip Jones, Angus Murray MacLeod, Robert James Maxey
Life of this patent
Estimating the term…
Loading patent…
AssigneeMerck Sharp & Dohme Corp.
InventorsHelen Jane Bryant, Mark Stuart Chambers, Philip Jones, Angus Murray MacLeod, Robert James Maxey
Estimating the term…
1 The present invention provides a compound of formula (I) in which R1 is generally hydrogen or CF3, R2 is generally hydrogen, W is a cyclic amine, a heterocycle or a group L-Y-X where L-Y is a linking portion and X is generally an aromatic or non-aromatic heterocycle, alkyl or alkylcarbonyl and Z is generally a heterocycle such as 5-methylisoxazol-3-yl, and pharmaceutically acceptable salts thereof for enhancing cognition in conditions such as Alzheimer's Disease, pharmaceutical compositions comprising them, their use for manufacturing medicaments and methods of treatment using them.
A compound of the formula (I):
A compound according to any preceding claim in which W is selected from:
A pharmaceutical composition comprising a compound according to any preceding claim or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.